These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26729947)

  • 21. Practical guide to understanding Comparative Effectiveness Research (CER).
    Neely JG; Sharon JD; Graboyes EM; Paniello RC; Nussenbaum B; Grindler DJ; Dassopoulos T;
    Otolaryngol Head Neck Surg; 2013 Dec; 149(6):804-12. PubMed ID: 24098005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacoeconomics comes of age?
    Walley T; Breckenridge A
    Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health technology assessment and comparative effectiveness research: a pharmaceutical industry perspective.
    Hao Y; Thomas A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):447-54. PubMed ID: 23977973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncertainties in real-world decisions on medical technologies.
    Lu CY
    Int J Clin Pract; 2014 Aug; 68(8):936-40. PubMed ID: 25074335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scientific and organizational collaboration in comparative effectiveness research: the VA cooperative studies program model.
    Huang GD; Ferguson RE; Peduzzi PN; O'Leary TJ
    Am J Med; 2010 Dec; 123(12 Suppl 1):e24-31. PubMed ID: 21184863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges.
    Perfetto EM; Anyanwu C; Pickering MK; Zaghab RW; Graff JS; Eichelberger B
    J Manag Care Spec Pharm; 2016 Jun; 22(6):609-16. PubMed ID: 27231789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness research in practice and policy for radiation oncology.
    Lawrence WF
    Semin Radiat Oncol; 2014 Jan; 24(1):54-60. PubMed ID: 24314343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decision support tools to optimize economic outcomes for type 2 diabetes.
    Shaya FT; Chirikov VV
    Am J Manag Care; 2011 Nov; 17 Suppl 14():S377-83. PubMed ID: 22214425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness research in the U.S.A.: when will there be an impact on healthcare decision-making?
    Westrich KD; Wilhelm JA; Schur CL
    J Comp Eff Res; 2016 Mar; 5(2):207-16. PubMed ID: 26844982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximizing the clinical utility of comparative effectiveness research.
    Umscheid CA
    Clin Pharmacol Ther; 2010 Dec; 88(6):876-9. PubMed ID: 20962776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
    Ahmed S; Berzon RA; Revicki DA; Lenderking WR; Moinpour CM; Basch E; Reeve BB; Wu AW;
    Med Care; 2012 Dec; 50(12):1060-70. PubMed ID: 22922434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH.
    Moloney R; Mohr P; Hawe E; Shah K; Garau M; Towse A
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):90-8. PubMed ID: 26168804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.
    Simonds NI; Khoury MJ; Schully SD; Armstrong K; Cohn WF; Fenstermacher DA; Ginsburg GS; Goddard KA; Knaus WA; Lyman GH; Ramsey SD; Xu J; Freedman AN
    J Natl Cancer Inst; 2013 Jul; 105(13):929-36. PubMed ID: 23661804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Looking at CER from the pharmaceutical industry perspective.
    Dubois RW
    J Manag Care Pharm; 2012 May; 18(4 Suppl A):S9-12. PubMed ID: 22578212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of observational investigations in comparative effectiveness research.
    Marko NF; Weil RJ
    Value Health; 2010 Dec; 13(8):989-97. PubMed ID: 21138497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public perceptions of comparative effectiveness research and use of evidence in healthcare decision-making.
    Cornwell D; Hu M; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):623-34. PubMed ID: 25494569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will lower drug prices jeopardize drug research? A policy fact sheet.
    Light DW; Lexchin J
    Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of Postapproval Evidence Generation on the Biopharmaceutical Industry.
    Milne CP; Cohen JP; Felix A; Chakravarthy R
    Clin Ther; 2015 Aug; 37(8):1852-8. PubMed ID: 26143223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The methods of comparative effectiveness research.
    Sox HC; Goodman SN
    Annu Rev Public Health; 2012 Apr; 33():425-45. PubMed ID: 22224891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness research: decision-based evidence.
    Kowalski CJ; Mrdjenovich AJ
    Perspect Biol Med; 2014; 57(2):224-48. PubMed ID: 25544326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.